Skip to main content
Erschienen in: Clinical Neuroradiology 4/2018

26.07.2017 | Original Article

Bioresorbable Vascular Scaffolds in Interventional Neuroradiology

verfasst von: Anil Arat, Ergun Daglioglu, Ilkay Akmangit, Ahmet Peker, Murat Arsava, Mehmet Akif Topcuoglu, Deniz Belen

Erschienen in: Clinical Neuroradiology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bioresorbable vascular scaffolds (BVS) have changed practice patterns in cardiology. These resorbable stents have not yet been utilized in the cerebrovascular circulation. We report the initial experiences with these devices in interventional neuroradiology.

Methods

A retrospective review of clinical presentations, imaging findings and follow-up results of all patients treated using a BVS by our neurovascular team was carried out using hospital electronic charts and the hospital radiographic archive system. Treatment was performed only if patients had a non-tortuous cerebrovascular anatomy suitable for navigation by the bulky BVS.

Results

In this study 9 patients (5 women, mean age 51.3 years) were treated with Absorb or DeSolve scaffolds without permanent morbidity or mortality, 5 had intracranial or vertebral artery stenosis and in 4 patients with cerebral aneurysms scaffold-assisted coiling was performed. At a mean follow-up of 22.3 months, 1 parent artery in the aneurysm group was occluded and the remaining BVSs showed no significant restenosis. Fusiform luminal enlargement was demonstrated in one aneurysm patient. In two patients treated for stenosis, transient intra-arterial filling defects resembling BVS struts (scaffold silhouette) was demonstrated on early follow-up angiograms. In the patient with parent artery occlusion (who was judged to have unjailed the internal carotid bifurcation) and in the patient with luminal remodeling, we were able to discontinue all antiplatelet medications at 3 years without any consequences.

Conclusion

Absorbable stent technology has potential applications in interventional neuroradiology. We suggest that BVS should be optimized for cerebral circulation if prospective studies are to be undertaken for cerebrovascular applications of BVS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tenekecioglu E, Farooq V, Bourantas CV, Silva RC, Onuma Y, Yılmaz M, Serruys PW. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:38.CrossRefPubMedPubMedCentral Tenekecioglu E, Farooq V, Bourantas CV, Silva RC, Onuma Y, Yılmaz M, Serruys PW. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:38.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Byrne RA, Kastrati A. Disappearing scaffolds, dissolving expectations. Lancet. 2016;388(10059):2451–2.CrossRefPubMed Byrne RA, Kastrati A. Disappearing scaffolds, dissolving expectations. Lancet. 2016;388(10059):2451–2.CrossRefPubMed
3.
Zurück zum Zitat Wang K, Yuan S, Zhang X, Liu Q, Zhong Q, Zhang R, Lu P, Li J. Biodegradable flow-diverting device for the treatment of intracranial aneurysm: short-term results of a rabbit experiment. Neuroradiology. 2013;55(5):621–8.CrossRefPubMed Wang K, Yuan S, Zhang X, Liu Q, Zhong Q, Zhang R, Lu P, Li J. Biodegradable flow-diverting device for the treatment of intracranial aneurysm: short-term results of a rabbit experiment. Neuroradiology. 2013;55(5):621–8.CrossRefPubMed
4.
Zurück zum Zitat Schellhammer F, Berlis A, Bloss H, Pagenstecher A, Schumacher M. Poly-lactic-acid coating for endovascular stents. Preliminary results in canine experimental arteriovenous fistulae. Invest Radiol. 1997;32(3):180–6.CrossRef Schellhammer F, Berlis A, Bloss H, Pagenstecher A, Schumacher M. Poly-lactic-acid coating for endovascular stents. Preliminary results in canine experimental arteriovenous fistulae. Invest Radiol. 1997;32(3):180–6.CrossRef
5.
Zurück zum Zitat Wang J, An Q, Li D, Wu T, Chen W, Sun B, El-Hamshary H, Al-Deyab SS, Zhu W, Mo X. Heparin and vascular endothelial growth factor loaded poly(L-lactide-co-caprolactone) nanofiber covered stent-graft for aneurysm treatment. J Biomed Nanotechnol. 2015;11(11):1947–60.CrossRef Wang J, An Q, Li D, Wu T, Chen W, Sun B, El-Hamshary H, Al-Deyab SS, Zhu W, Mo X. Heparin and vascular endothelial growth factor loaded poly(L-lactide-co-caprolactone) nanofiber covered stent-graft for aneurysm treatment. J Biomed Nanotechnol. 2015;11(11):1947–60.CrossRef
6.
Zurück zum Zitat Wang JB, Zhou B, Gu XL, Li MH, Gu BX, Wang W, Li YD. Treatment of a canine carotid artery aneurysm model with a biodegradable nanofiber-covered stent: a prospective pilot study. Neurol India. 2013;61(3):282–7.CrossRefPubMed Wang JB, Zhou B, Gu XL, Li MH, Gu BX, Wang W, Li YD. Treatment of a canine carotid artery aneurysm model with a biodegradable nanofiber-covered stent: a prospective pilot study. Neurol India. 2013;61(3):282–7.CrossRefPubMed
7.
Zurück zum Zitat Aoun RJ, Sattur MG, Panchanathan RS, Bendok BR. The ABSORB III trial: potential new concepts for intracranial atherosclerosis in the post-SAMMPRIS era. Neurosurgery. 2016;78(2):N19–N20.CrossRefPubMed Aoun RJ, Sattur MG, Panchanathan RS, Bendok BR. The ABSORB III trial: potential new concepts for intracranial atherosclerosis in the post-SAMMPRIS era. Neurosurgery. 2016;78(2):N19–N20.CrossRefPubMed
8.
Zurück zum Zitat He D, Liu W, Zhang T. The development of carotid stent material. Interv Neurol. 2015;3(2):67–77.CrossRefPubMed He D, Liu W, Zhang T. The development of carotid stent material. Interv Neurol. 2015;3(2):67–77.CrossRefPubMed
9.
Zurück zum Zitat Indolfi C, De Rosa S, Colombo A. Bioresorbable vascular scaffolds – basic concepts and clinical outcome. Nat Rev Cardiol. 2016;13(12):719–29.CrossRefPubMed Indolfi C, De Rosa S, Colombo A. Bioresorbable vascular scaffolds – basic concepts and clinical outcome. Nat Rev Cardiol. 2016;13(12):719–29.CrossRefPubMed
10.
Zurück zum Zitat Kereiakes DJ, Onuma Y, Serruys PW, Stone GW. Bioresorbable vascular scaffolds for coronary revascularization. Circulation. 2016;134(2):168–82.CrossRefPubMed Kereiakes DJ, Onuma Y, Serruys PW, Stone GW. Bioresorbable vascular scaffolds for coronary revascularization. Circulation. 2016;134(2):168–82.CrossRefPubMed
11.
Zurück zum Zitat Deloose K, Bosiers M, Callaert J. TVR Reduction in the SFA. Endovascular today. 2014 October Deloose K, Bosiers M, Callaert J. TVR Reduction in the SFA. Endovascular today. 2014 October
12.
Zurück zum Zitat Strandberg E, Zeltinger J, Schulz DG, Kaluza GL. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv. 2012;5(1):39–46.CrossRefPubMed Strandberg E, Zeltinger J, Schulz DG, Kaluza GL. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv. 2012;5(1):39–46.CrossRefPubMed
13.
Zurück zum Zitat Bontinck J, Goverde P, Schroe H, Hendriks J, Maene L, Vermassen F. Treatment of the femoropopliteal artery with the bioresorbable remedy stent. J Vasc Surg. 2016;64(5):1311–9.CrossRefPubMed Bontinck J, Goverde P, Schroe H, Hendriks J, Maene L, Vermassen F. Treatment of the femoropopliteal artery with the bioresorbable remedy stent. J Vasc Surg. 2016;64(5):1311–9.CrossRefPubMed
14.
Zurück zum Zitat Kaya T, Daglioglu E, Gurkas E, Akmangit I, Peker A, Belen D, Dede D, Elhan AH, Arat A. Silk device for the treatment of Intracranial aneurysms, part 2: factors related to clinical and angiographic outcome. Turk Neurosurg. 2016;26(4):533–7.CrossRefPubMed Kaya T, Daglioglu E, Gurkas E, Akmangit I, Peker A, Belen D, Dede D, Elhan AH, Arat A. Silk device for the treatment of Intracranial aneurysms, part 2: factors related to clinical and angiographic outcome. Turk Neurosurg. 2016;26(4):533–7.CrossRefPubMed
15.
Zurück zum Zitat Charpentier E, Barna A, Guillevin L, Juliard JM. Fully bioresorbable drug-eluting coronary scaffolds: a review. Arch Cardiovasc Dis. 2015;108(6):385–97.CrossRefPubMed Charpentier E, Barna A, Guillevin L, Juliard JM. Fully bioresorbable drug-eluting coronary scaffolds: a review. Arch Cardiovasc Dis. 2015;108(6):385–97.CrossRefPubMed
16.
Zurück zum Zitat Picard F, L’Allier PL, Tanguay JF. Early multiple coronary micro aneurysms after bioresorbable vascular scaffold implantation. Can J Cardiol. 2016;33(2):292.e9–292.e11.CrossRef Picard F, L’Allier PL, Tanguay JF. Early multiple coronary micro aneurysms after bioresorbable vascular scaffold implantation. Can J Cardiol. 2016;33(2):292.e9–292.e11.CrossRef
18.
Zurück zum Zitat Collet C, de Winter RJ, Onuma Y, Serruys PW. The Absorb bioresorbable vascular scaffold for the treatment of coronary artery disease. Expert Opin Drug Deliv. 2016;13(10):1489–99.CrossRefPubMed Collet C, de Winter RJ, Onuma Y, Serruys PW. The Absorb bioresorbable vascular scaffold for the treatment of coronary artery disease. Expert Opin Drug Deliv. 2016;13(10):1489–99.CrossRefPubMed
19.
Zurück zum Zitat Mukete BN, van der Heijden LC, Tandjung K, Baydoun H, Yadav K, Saleh QA, Doggen CJ, Abi Rafeh N, Le Jemtel TH, von Birgelen C. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1‑year follow-up: A systematic review and meta-analysis of studies. Int J Cardiol. 2016;221:1087–94.CrossRefPubMed Mukete BN, van der Heijden LC, Tandjung K, Baydoun H, Yadav K, Saleh QA, Doggen CJ, Abi Rafeh N, Le Jemtel TH, von Birgelen C. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1‑year follow-up: A systematic review and meta-analysis of studies. Int J Cardiol. 2016;221:1087–94.CrossRefPubMed
20.
Zurück zum Zitat Serruys PW, Ormiston J, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Chevalier B, Smits P, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Wasungu L, Ediebah D, Veldhof S, Onuma Y. A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5‑year follow-up. J Am Coll Cardiol. 2016;67(7):766–76.CrossRefPubMed Serruys PW, Ormiston J, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Chevalier B, Smits P, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Wasungu L, Ediebah D, Veldhof S, Onuma Y. A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5‑year follow-up. J Am Coll Cardiol. 2016;67(7):766–76.CrossRefPubMed
21.
Zurück zum Zitat Giordano A, Messina S, Biondi-Zoccai G. Successful treatment of a subclavian artery stenosis with a coronary bioresorbable vascular scaffold. J Endovasc Ther. 2016;23(4):653–6.CrossRefPubMed Giordano A, Messina S, Biondi-Zoccai G. Successful treatment of a subclavian artery stenosis with a coronary bioresorbable vascular scaffold. J Endovasc Ther. 2016;23(4):653–6.CrossRefPubMed
22.
Zurück zum Zitat Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Biondi-Zoccai G. Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: a case report. Int J Surg Case Rep. 2016;21:78–82.CrossRefPubMedPubMedCentral Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Biondi-Zoccai G. Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: a case report. Int J Surg Case Rep. 2016;21:78–82.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Park JB, Bronzino JD. Biomaterials: principles and applications. Boca Raton: CRC Press; 2002.CrossRef Park JB, Bronzino JD. Biomaterials: principles and applications. Boca Raton: CRC Press; 2002.CrossRef
24.
Zurück zum Zitat Wang Y. New biomaterials derived from poly (lactic acids): novel approaches to combine biodegradation, x‑ray contrast and controlled local drug release. Maastricht: Maastricht University; 2015. Wang Y. New biomaterials derived from poly (lactic acids): novel approaches to combine biodegradation, x‑ray contrast and controlled local drug release. Maastricht: Maastricht University; 2015.
25.
Zurück zum Zitat McDougall CG, Johnston SC, Gholkar A, Barnwell SL, Vazquez Suarez JC, Massó Romero J, Chaloupka JC, Bonafe A, Wakhloo AK, Tampieri D, Dowd CF, Fox AJ, Imm SJ, Carroll K, Turk AS; MAPS Investigators. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol. 2014;35(5):935–42.CrossRefPubMed McDougall CG, Johnston SC, Gholkar A, Barnwell SL, Vazquez Suarez JC, Massó Romero J, Chaloupka JC, Bonafe A, Wakhloo AK, Tampieri D, Dowd CF, Fox AJ, Imm SJ, Carroll K, Turk AS; MAPS Investigators. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol. 2014;35(5):935–42.CrossRefPubMed
26.
Zurück zum Zitat Molyneux AJ, Clarke A, Sneade M, Mehta Z, Coley S, Roy D, Kallmes DF, Fox AJ. Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012;43(10):2544–50.CrossRefPubMed Molyneux AJ, Clarke A, Sneade M, Mehta Z, Coley S, Roy D, Kallmes DF, Fox AJ. Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012;43(10):2544–50.CrossRefPubMed
27.
Zurück zum Zitat Cuellar H, Guimaraens L, Ambekar S, Vivas E, Theron J. Angioseal as a hemostatic device for direct carotid puncture during endovascular procedures. Interv Neuroradiol. 2015;21(2):273–6.CrossRefPubMedPubMedCentral Cuellar H, Guimaraens L, Ambekar S, Vivas E, Theron J. Angioseal as a hemostatic device for direct carotid puncture during endovascular procedures. Interv Neuroradiol. 2015;21(2):273–6.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Gasbarro V, Traina L, Mascoli F, Coscia V, Buffone G, Grande R, Fugetto F, Butrico L, de Franciscis S, Serra R. Absorbable suture material in carotid surgery. Vasa. 2015;44(6):451–7.CrossRefPubMed Gasbarro V, Traina L, Mascoli F, Coscia V, Buffone G, Grande R, Fugetto F, Butrico L, de Franciscis S, Serra R. Absorbable suture material in carotid surgery. Vasa. 2015;44(6):451–7.CrossRefPubMed
29.
Zurück zum Zitat Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg. 2004;100(4):688–94.CrossRefPubMed Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg. 2004;100(4):688–94.CrossRefPubMed
30.
Zurück zum Zitat Levy EI, Hanel RA, Tio FO, Garlick DS, Bailey L, Cunningham MR, Williard C, Sherman D, Dooley JF, Kopia GA. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment. Neurosurgery. 2006;59(4):925–33, discussion 933–4.CrossRefPubMed Levy EI, Hanel RA, Tio FO, Garlick DS, Bailey L, Cunningham MR, Williard C, Sherman D, Dooley JF, Kopia GA. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment. Neurosurgery. 2006;59(4):925–33, discussion 933–4.CrossRefPubMed
31.
Zurück zum Zitat Arat A, Diaz O, Strother C, Klucznik R. Comparison of drug eluting-balloon expandable and self expandable stents for stenting of intracranial atherosclerosis. Interv Neuroradiol. 2009;15(Suppl 1):97. Arat A, Diaz O, Strother C, Klucznik R. Comparison of drug eluting-balloon expandable and self expandable stents for stenting of intracranial atherosclerosis. Interv Neuroradiol. 2009;15(Suppl 1):97.
32.
Zurück zum Zitat Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37(10):2562–6.CrossRefPubMed Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37(10):2562–6.CrossRefPubMed
33.
Zurück zum Zitat Park S, Lee DG, Chung WJ, Lee DH, Suh DC. Long-term outcomes of drug-eluting stents in symptomatic Intracranial stenosis. Neurointervention. 2013;8(1):9–14.CrossRefPubMedPubMedCentral Park S, Lee DG, Chung WJ, Lee DH, Suh DC. Long-term outcomes of drug-eluting stents in symptomatic Intracranial stenosis. Neurointervention. 2013;8(1):9–14.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Natarajan SK, Ogilvy CS, Hopkins LN, Siddiqui AH, Levy EI. Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis. J Neurointerv Surg. 2010;2(2):104–9.CrossRefPubMed Natarajan SK, Ogilvy CS, Hopkins LN, Siddiqui AH, Levy EI. Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis. J Neurointerv Surg. 2010;2(2):104–9.CrossRefPubMed
35.
Zurück zum Zitat Costa JR Jr, Abizaid A, Feres F, Costa R, Seixas AC, Maia F, Abizaid A, Tanajura LF, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa AG, Fitzgerald P, Sousa JE. Excella First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 2008;4(1):53–8.CrossRef Costa JR Jr, Abizaid A, Feres F, Costa R, Seixas AC, Maia F, Abizaid A, Tanajura LF, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa AG, Fitzgerald P, Sousa JE. Excella First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 2008;4(1):53–8.CrossRef
36.
Zurück zum Zitat Zhang F, Qian J, Dong L, Ge J. Coronary aneurysm formation following biodegradable polymer drug-eluting stent implantation. Int J Cardiol. 2012;160(1):e8–e9.CrossRefPubMed Zhang F, Qian J, Dong L, Ge J. Coronary aneurysm formation following biodegradable polymer drug-eluting stent implantation. Int J Cardiol. 2012;160(1):e8–e9.CrossRefPubMed
37.
Zurück zum Zitat Karanasos A, Garcia-Garcia HM, van Geuns RJ, Regar E. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations. JACC Cardiovasc Interv. 2015;8(3):e53–e4.CrossRefPubMed Karanasos A, Garcia-Garcia HM, van Geuns RJ, Regar E. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations. JACC Cardiovasc Interv. 2015;8(3):e53–e4.CrossRefPubMed
38.
Zurück zum Zitat Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW; ABSORB EXTEND investigators. The absorb extend study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10(12):1396–401.CrossRefPubMed Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW; ABSORB EXTEND investigators. The absorb extend study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10(12):1396–401.CrossRefPubMed
39.
Zurück zum Zitat Lafont A, Durand E. A.R.T.: concept of a bioresorbable stent without drug elution. EuroIntervention. 2009;5(Suppl F):F83–F7.CrossRefPubMed Lafont A, Durand E. A.R.T.: concept of a bioresorbable stent without drug elution. EuroIntervention. 2009;5(Suppl F):F83–F7.CrossRefPubMed
40.
Zurück zum Zitat Butteriss D, Gholkar A, Mitra D, Birchall D, Jayakrishnan V. Single-center experience of cerecyte coils in the treatment of intracranial aneurysms: initial experience and early follow-up results. AJNR Am J Neuroradiol. 2008;29(1):53–6.CrossRefPubMed Butteriss D, Gholkar A, Mitra D, Birchall D, Jayakrishnan V. Single-center experience of cerecyte coils in the treatment of intracranial aneurysms: initial experience and early follow-up results. AJNR Am J Neuroradiol. 2008;29(1):53–6.CrossRefPubMed
41.
Zurück zum Zitat Ramot Y, Haim-Zada M, Domb AJ, Nyska A. Biocompatibility and safety of PLA and its copolymers. Adv Drug Deliv Rev. 2016;107:153–62.CrossRefPubMed Ramot Y, Haim-Zada M, Domb AJ, Nyska A. Biocompatibility and safety of PLA and its copolymers. Adv Drug Deliv Rev. 2016;107:153–62.CrossRefPubMed
42.
Zurück zum Zitat Collet C, Serruys PW. Polymer biodegradation kinetics: Do they matter? J Am Coll Cardiol. 2016;67(19):2259–62.CrossRefPubMed Collet C, Serruys PW. Polymer biodegradation kinetics: Do they matter? J Am Coll Cardiol. 2016;67(19):2259–62.CrossRefPubMed
43.
Zurück zum Zitat Rudolph A, Teske M, Illner S, Kiefel V, Sternberg K, Grabow N, Wree A, Hovakimyan M. Surface modification of biodegradable polymers towards better biocompatibility and lower thrombogenicity. PLoS One. 2015;10(12):e0142075.CrossRefPubMedPubMedCentral Rudolph A, Teske M, Illner S, Kiefel V, Sternberg K, Grabow N, Wree A, Hovakimyan M. Surface modification of biodegradable polymers towards better biocompatibility and lower thrombogenicity. PLoS One. 2015;10(12):e0142075.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Kono K, Terada T. Feasibility of insertion of a microcatheter through a Y-stent in coil embolization of cerebral aneurysms and its detailed geometry by micro-computed tomography. Acta Neurochir (Wien). 2014;156(1):39–43.CrossRef Kono K, Terada T. Feasibility of insertion of a microcatheter through a Y-stent in coil embolization of cerebral aneurysms and its detailed geometry by micro-computed tomography. Acta Neurochir (Wien). 2014;156(1):39–43.CrossRef
45.
Zurück zum Zitat Topcuoglu OM, Akgul E, Daglioglu E, Topcuoglu ED, Peker A, Akmangit I, Belen D, Arat A. Flow diversion in middle cerebral artery aneurysms: Is it really an all-purpose treatment? World Neurosurg. 2016;87:317–27.CrossRefPubMed Topcuoglu OM, Akgul E, Daglioglu E, Topcuoglu ED, Peker A, Akmangit I, Belen D, Arat A. Flow diversion in middle cerebral artery aneurysms: Is it really an all-purpose treatment? World Neurosurg. 2016;87:317–27.CrossRefPubMed
Metadaten
Titel
Bioresorbable Vascular Scaffolds in Interventional Neuroradiology
verfasst von
Anil Arat
Ergun Daglioglu
Ilkay Akmangit
Ahmet Peker
Murat Arsava
Mehmet Akif Topcuoglu
Deniz Belen
Publikationsdatum
26.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 4/2018
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-017-0609-5

Weitere Artikel der Ausgabe 4/2018

Clinical Neuroradiology 4/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.